With 1.85 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.95 million shares. The 52-week range on CRS shows that it touched its highest point at $213.66 and its lowest point at $63.58 during that stretch. It currently has a 1-year price target of $234.17. With its current market cap of 9.00 billion, CRS has annualized dividend of $0.80 while the current yield stands at 0.44%. Beta for the stock currently stands at 1.28.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRS was down-trending over the past week, with a drop of -12.94%, but this was down by -6.45% over a month. Three-month performance dropped to -6.45% while six-month performance rose 32.88%. The stock gained 183.24% in the past year, while it has gained 6.23% so far this year. A look at the trailing 12-month EPS for CRS yields 5.30 with Next year EPS estimates of 8.87. For the next quarter, that number is 1.73. This implies an EPS growth rate of 50.99% for this year and 23.96% for next year. EPS is expected to grow by 33.23% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 1.52%.
Float and Shares Shorts:
At present, 49.88 million CRS shares are outstanding with a float of 47.89 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRS since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $4.48271 being high and $4.24557 being low. For CRS, this leads to a yearly average estimate of $4.47264. Based on analyst estimates, the high estimate for the next quarter is $2.11 and the low estimate is $1.94. The average estimate for the next quarter is thus $2.03.
